27 results on '"Andresen, S."'
Search Results
2. Timing of High Dose Melphalan (HDM) and Outcomes for Autologous Stem Cell Transplantation (ASCT) in Patients With Multiple Myeloma (MM)
3. 60: A high lactate dehydrogenase (LDH) level predicts for shorter survival following HLA-matched sibling bone marrow transplant (BMT) for patients with acute myelogenous leukemia (AML)
4. T cell (CD3+) chimerism after non-myeloablative allogeneic hematopoietic stem cell transplantation (NMHSCT)
5. Intravenous Compared to Oral Busulfan with Cyclophosphamide for Autologous Hematopoietic Progenitor Cell Transplant Conditioning for Plasma Cell Myeloma
6. Risk Factors for the Development of Graft Versus Host Disease in Allogeneic Hematopoietic Stem Cell Tranplantation (allo-HSCT)
7. Predictive Factors for Adverse Outcomes After Use of Donor Cell Infusion (DCI) in Patients with Relapsed Hematological Malignancies Treated with Allogeneic Hematopoietic Cell Transplantation (alloHCT)
8. Repeat Readmissions After Allogeneic Hematopoietic Progenitor Cell Transplantation (HPCT)
9. Early Readmission Rates After Autologous and Allogeneic Hematopoietic Progenitor Cell Transplantation (HPCT)
10. Immunogenicity of Polysaccharide Pneumococcal Vaccination in Autologous Hematopoietic Stem Cell Transplantation
11. The Slope of Circulating Blast Clearance Does Not Predict Disease Relapse After Allogeneic Stem Cell Transplantation
12. The T-Cell Epitope (TCE) Algorithm for Classifying HLA-DPB1 Mismatches Does Not Predict Clinical Outcomes in HSCT
13. Predictive Factors for Hospitalization After Outpatient Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Progenitor Cell Transplantation (AHPCT)
14. Sustained High-Dose Corticosteroid Use Does Not Independently Diminish Survival After Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation
15. Readmission Rates After Autologous Hematopoietic Stem Cell Transplantation
16. Multiple Unit Umbilical Cord Blood Transplantation (MU UCBT) With Total Body Irradiation, Etoposide And Antithymocyte Globulin For Adult Hematologic Malignancy Patients
17. Treatment With Hyper-CVAD Results In Poor Mobilization Of Peripheral Blood Stem Cells In Patients With Mantle Cell Lymphoma
18. Multiple Unit Umbilical Cord Blood Transplantation (MU UCBT) With Total Body Irradiation, Etoposide And Antithymocyte Globulin For Adult Hematologic Malignancy Patients
19. Readmission Rates After Autologous Hematopoietic Stem Cell Transplantation
20. Treatment With Hyper-CVAD Results In Poor Mobilization Of Peripheral Blood Stem Cells In Patients With Mantle Cell Lymphoma
21. Minimal Mortality from Veno-Occlusive Disease Following Busulfan-Based Preparative Regimens: A Large Single Institution Experience
22. T-Cell Engraftment Kinetics Following Myeloablative and Nonmyeloablative Regimens for Allogeneic Hematopoietic Transplantation
23. Busulfan and Cyclophosphamide has Similar Outcomes to High Dose Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation In Patients With Multiple Myeloma
24. Diagnosis of Mental Health Disorder Does Not Effect Outcome in Allogeneic Bone Marrow Transplant
25. CD34+ Cell Yield on Day 1 of Apheresis Predicts Total CD34+ Cell Mobilization, Neutrophil Recovery, and Survival After Autologous Stem Cell Transplantation for Lymphoma
26. Predictors and Impact of Donor T-cell Chimerism in Myeloablative Allogeneic Stem Cell Transplantation
27. 327: Influence of killer immunoglobulin-like receptor (KIR) matching on the development of chronic graft-vs.-host disease (cGVHD) in T-cell depleted matched unrelated donor (MUD) allogeneic bone marrow transplantation (alloBMT)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.